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Abstract: Sofrito is a mix of tomato, onion, garlic, and olive oil, which contains phenolic compounds and
carotenoids. Consumption of tomato-based sofrito has been related to a lower risk of cardiovascular
events, but the mechanisms behind such beneficial effects remain unclear. This study aimed to analyze
the effects of representative sofrito compounds such as naringenin, hydroxytyrosol, lycopene, and
β-carotene on mechanisms involved in the pathogenesis of atherosclerosis. We demonstrated that
both phenolic compounds and both carotenoids studied were able to inhibit low density lipoproteins
(LDL) oxidation, as well as oxidative stress and eicosanoid production induced by oxidized LDL
(oxLDL) in macrophage cultures. These effects were not the consequences of disturbing oxLDL
uptake by macrophages. Finally, we observed an additive effect of these sofrito compounds, as well as
the activity of a main naringenin metabolite, naringenin 7-O-β-d-glucuronide on LDL oxidation and
oxidative stress.
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1. Introduction
Epidemiologic and prospective studies have provided strong evidence that a diet rich in a variety of
fruits and vegetables, such as the Mediterranean diet, results in a lower risk of developing cardiovascular
diseases (CVD) [1–3]. In this way, tomato and tomato-based products have been associated with
decreased levels of cardiovascular risk factors [4–6]. However, the bioactive compounds and the
mechanisms behind such beneficial effects remain unclear.
Sofrito is not a unique recipe but usually contents a mix of ingredients such as tomato, onion, garlic
and olive oil, which contains many bioactive phenolic compounds and carotenoids [7]. Naringenin
and chalcone naringenin, a naringenin precursor, are accepted as the main flavonoids in tomatoes and
tomato-based sauces [8,9], whereas lycopene and β-carotene are the more representative carotenoids [7]
and hydroxytyrosol appears in sofrito and tomato sauces prepared with olive oil [7]. Interestingly,
sofrito has higher levels of bioactive compounds than tomato. Thus, 120 g of sofrito added to different
dishes daily, leads to a total phenolic intake of 15–25 mg and 5–10 mg of carotenoids. Recently, it was
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reported that some of these compounds could modulate oxidative stress and eicosanoid production [10],
involved in chronic processes with an important inflammatory component, such as CVD.
The protective beneficial effects of tomato sauces have been mainly attributed to their capacity to
prevent atherogenesis by their antioxidant properties [11,12]. However, few studies have demonstrated
anti-atherogenic effects for narigenin [13] or lycopene [14]. Thus, the action of sofrito bioactive
compounds on the main mechanisms involved in CVD remains to be investigated. Low-density
lipoproteins (LDL) oxidation is an early and critical event in atherogenesis [15,16]. However, high levels
of oxidized LDL (oxLDL) correlate with the severity of CVD [17], and oxLDL uptake by macrophages
promotes the recruitment of leukocytes and accumulation of lipid-laden macrophages named foam
cells [18], which are the most predominant cell type in the fatty streaks [19].
Considering the above mentioned observations, we aimed to study the effect of compounds found
in sofrito on oxidation of LDL, as well as on oxidative stress and eicosanoid production by macrophages
incubated in the presence of oxLDL, important events implicated in the pathogenesis of atherosclerosis.
2. Materials and Methods
2.1. Materials and Chemicals
Naringenin, lycopene,β-carotene, hydroxytyrosol, 1,1′-dioctadecyl-3,3,3′,3′ tetra-methylindocarbocyanine
perchlorate (Dil), p-nitro blue tetrazolium (NBT), phorbol myristate-acetate (PMA), superoxide
dismutase (SOD), catalase, and fucoidan were obtained from Sigma Chemical Co. (St. Louis, MO,
USA). Naringenin 7-O-β-d-glucuronide was obtained from Cayman Chem. Co. (Ann Arbor, MI,
USA). Cell culture medium, foetal bovine serum and supplements were obtained from GE Healthcare
Hyclone (Logan, UT, USA). All other reagents were of analytical grade. Assayed compounds were
dissolved in dimethylsulfoxide (DMSO) and the final concentration of DMSO in cell cultures was
lower than 0.1%.
2.2. Culture of Human Monocyte/Macrophage
Human monocyte cell line THP-1 was obtained from American Type Culture Collection (ATCC,
Manassas, VA, USA). The cells were maintained at a maximal density of 1 × 106 cells/mL in RPMI
1640 medium containing 10% fetal bovine serum and 1% penicillin/streptomycin solution at 37 ◦C
in a 5% CO2 incubation. To induce macrophage differentiation, THP-1 cell (1 × 105 cells/well) were
incubated in multi-well plates in the presence of 100 nM PMA for 48 h to complete the morphological
and biochemical differentiation to macrophages [20].
2.3. Isolation of LDL and LDL Oxidation Assay
LDL (density 1.03–1.053) were prepared by sequential ultracentrifugation from pooled, citrated
human plasma from six healthy normolipidemic volunteers (personnel of the laboratory), according to
the method of Chung et al. [21]. Finally, LDL were dialysed, filtered through a 0.45 µM filter and stored
at 4 ◦C. The protein concentration was determined by the Lowry method modified by Peterson [22].
LDL were diluted with PBS to a final concentration of 50 µg protein/mL and incubated at 37 ◦C
with freshly prepared CuSO4·5H2O (2.5 µM) in the presence of the tested compounds. Conjugated
dienes (CD) were monitored spectrophotometrically (234 nm) every 5 min as described by Esterbauer
et al. [23] and thiobarbituric acid reactive substances (TBARs) measured fluorimetrically (excitation at
515 nm and emission at 553 nm) according to the method described by Yagi [24].
2.4. Assay for Binding and/or Uptake of oxLDL by Macrophages
In order to elucidate whether the effects observed were a consequence of disturbing oxLDL uptake
by macrophages, oxLDL were labelled using the fluorescent probe Dil according to the methodology
described by Innerarity et al. [25]. Thus, oxLDL (1 mg protein/mL) were incubated overnight with Dil
(30 µg/mL) at 37 ◦C and, finally, Dil-labelled oxLDL were isolated by ultracentrifugation. The medium
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was removed and macrophages were incubated in the presence of studied compounds and finally
Dil-labelled oxLDL (50 µg protein/mL) or unlabelled oxLDL (50 µg protein/mL) were incubated for
3 h. After being washed three times with PBS, cells were lysed with 0.1 M NaOH, and the solution
was neutralised with 0.1 M HCl. Fluorescence intensity was measured with a spectrofluorometer
(excitation at 524 nm and emission at 567 nm) [26].
2.5. Determination of Reactive Oxygen Species (ROS) and Nitric Oxide (NO) Production
The medium was removed from macrophage cultures, which were incubated with the testing
compounds for 30 min and then stimulated with oxLDL (50 µg protein/mL) for 30 min. Superoxide
anion (O2−) generation was determined in aliquots of culture supernatant by measuring the superoxide
dismutase-inhibitable reduction of NBT [27]. Nitrite (NO2−) accumulation in the cell-free medium, an
indicator of NO production, was measured using the Griess reagent as we described previously [27].
2.6. Measurement of Prostaglandin E2 (PGE2) and Leukotriene B4 (LTB4)
The medium of macrophage cultures was removed and testing compounds were incubated for
30 min, and then macrophages were stimulated with oxLDL (50 µg protein/mL) for 30 min. An aliquot
of culture medium (0.25 mL) was acidified with 1 mL of 1% formic acid. PGE2 or LTB4 was extracted in
ethyl acetate (5 mL) and, after discarding the aqueous phase, the organic phase was evaporated under
a stream of nitrogen. PGE2 and LTB4 levels were determined using monoclonal enzyme immunoassay
kits (Cayman Chemical Co., Ann Arbor, MI, USA) following the manufacturer’s protocol.
2.7. Statistical Analysis
Results are expressed as mean ± SEM. Differences between control and treated samples were
tested using either Student’s t-test or one-way analysis of variance, followed by the least significant
differences test when appropriate differences were considered statistically significant at p < 0.05.
3. Results
3.1. Sofrito Compounds Modulate LDL Oxidation Induced by Cu2+
To mimic in vivo conditions, pooled plasma was preincubated with the compounds under study at
37 ◦C for 1 h. LDL were subsequently isolated and its resistance to oxidation induced by Cu2SO4 tested.
CD and TBARs production were reduced by the presence of bioactive compounds, and hydroxytyrosol
and naringenin being more effective than lycopene or β-carotene (Table 1). Our results show an
additive effect of these compounds at 1 µM that was able to delay LDL oxidation.
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Table 1. Effect of sofrito bioactive compounds of on Cu2+ mediated oxidation of low-density lipoproteins
LDL, which was monitored by conjugated dienes (CD) and thiobarbituric acid reactive substances
(TBARs) formation. Tlag was the difference in lag phase (min) between Cu2+ and Cu2+ plus tested
compounds. ∆Tlag (%) = sample Tlag − control Tlag/control Tlag (× 100). MDA is expressed as nmol/mg
of LDL protein. Superoxide dismutase (SOD) (30 µM) and catalase (50 µM) were used as positive control.
Results are expressed as means ± SEM of two experiments performed in triplicate. * Significantly
different from Cu2+ without treatments.
CD TBARs
Tlag (min) ∆Tlag (%) MDA
LDL 3.2 ± 0.2
LDL + Cu2+ 58 ± 6 27.3 ± 1.3
LDL + Cu2+ + Naringenin (1 µM) 97 ± 7 * 67.2 19.5 ± 0.7 *
LDL + Cu2+ + Naringenin (10 µM) 198 ± 13 * 241.4 12.1 ± 0.4 *
LDL + Cu2+ + Naringenin Gluc. (10 µM) 204 ± 12 * 251.7 13.6 ± 0.3 *
LDL + Cu2+ + Hydroxytyrosol (1 µM) 225 ± 11 * 287.9 14.8 ± 0.3 *
LDL + Cu2+ + Hydroxytyrosol (10 µM) >500 * 8.3 ± 0.2 *
LDL + Cu2+ + Lycopene (10 µM) 73 ± 6 25.8 22.5 ± 0.4
LDL + Cu2+ + Lycopene (50 µM) 121 ± 8 * 108.6 15.7 ± 0.3 *
LDL + Cu2+ + β Carotene (10 µM) 72 ± 5 24.1 23.8 ± 0.4
LDL + Cu2+ + β Carotene (50 µM) 119 ± 7 * 105.2 17.9 ± 0.3 *
LDL + Cu2+ + all compounds (1 µM) 386 ± 8 * 565.5 10.6 ± 0.2 *
LDL + Cu2+ + SOD + Catalase >500 * 5.7 ± 0.2 *
Bioactive compound concentrations was chosen considering the plasma and tissue levels reached
after sofrito ingestion [8].
3.2. Phenolic Compounds and Carotenoids of Sofrito Reduce Oxidative Stress and Eicosanoid Synthesis Induced
by oxLDL
OxLDL (50 µg protein/mL) induced O2− and NO2− formation with maximum levels reached
30 min after macrophages stimulation (Table 2). We observed no cell toxicity using this range of
concentration of oxLDL and the exogenous addition of superoxide dismutase (SOD) or catalase inhibited
oxidative stress induced by oxLDL in these experimental conditions (data not shown). Furthermore,
we observed that oxLDL were able to induce cyclooxygenase and 5-lipoxygenase pathways reflected
in the enhancement of PGE2 and LTB4 synthesis in macrophage cultures (Table 2).
Table 2. Effects of naringenin and naringenin 7-O-β-d-glucuronide on reactive oxygen species (ROS),
NO), PGE2 and leukotriene B4 (LTB4) production by macrophages in the presence of oxidized LDLs
(oxLDLs). ROS are expressed as O2− (nmol/mL), NO was indirectly determined as NO2− (nmol/mL),
and PGE2 and LTB4 concentration in cell culture supernatant were expressed as pg/mL. Naringenin
and naringenin 7-O-β-d-glucuronide (10 µM) were incubated for 30 min and then stimulated with
oxLDL for 30 min a 37 ◦C. Data are the means ± SEM. of three experiments performed in triplicate.
* p < 0.05 versus control, , p < 0.05 versus non-treated cells.
ROS NO PGE2 LTB4
Control 2.0 ± 0.1 1.3 ± 0.1 2.5 ± 0.5 1.8 ± 0.4
oxLDL 15.4 ± 1.6 * 32.1 ± 2.7 * 26.8 ± 2.6 * 21.2 ± 1.8 *
oxLDL + Naringenin 6.3 ± 0.8 , 12.4 ± 1.3 , 11.6 ± 2.1 , 13.5 ± 1.4 ,
oxLDL + Naringenin 7-O-β-gluc. 7.6 ± 1.2 , 13.6 ± 1.5 , 13.2 ± 2.5 , 15.1 ± 1.3 ,
The present work shows that naringenin (0.1–25 µM), hydroxytyrosol (0.1–10 µM), lycopene
(1–50 µM), and β-carotene (1–50 µM) decreased in a concentration-dependent manner the production of
O2− and NO2− produced by oxLDL stimulated macrophages, as indicators of ROS and NO production,
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respectively (Figure 1). In a similar form, these compounds decreased the oxLDL induced biosynthesis
of eicosanoids representative of cyclooxygenase and 5-lipoxygenase pathways such as PGE2 and LTB4,
respectively (Figure 2).Nutrients 2019, 11, x FOR PEER REVIEW 5 of 11 
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naringenin (10 μM), hydroxytyrosol (10 μM), lycopene (50 μM), or β-carotene (50 µM) did not modify 
fluorescence intensity induced by Dil-labelled oxLDL, whereas fucoidan (10 µg/mL), a polyanionic 
polysaccharide, effective competitor for oxLDL in studies of receptor binding [28], prevented the 
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Figure 1. Effect of bioactive compounds of sofrito on O2− and NO2− production stimulated by oxLDL.
Macrophages were incubated with naringenin (), hydroxytyrosol (), lycopene (N), or β-carotene ()
for 30 min, and then stimulated with oxLDL (50 µg protein/mL) for 30 min. Finally, O2− and NO2−
were measured. Data are the means ± SEM of three experiments performed in triplicate.
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Figure 2. Effect of bioactive compounds of sofrito on prostaglandin E2 and leukotriene B4 production
stimulated by oxLDL. Macrophages were incubated with naringenin (), hydroxytyrosol (), lycopene
(N), or β-carotene () for 30 min, and then stimulated with oxLDL (50 µg protein/mL) for 30 min. Finally,
PGE2 or LTB4 were measured. Data are the means ± SEM of three experiments performed in triplicate.
Interestingly, we did not observe any effect of these compounds on non-stimulated cells (data not
shown), but we observed an additive effect of these compounds on O2−, PGE2, and LTB4 formation
induced by oxLDL (Figure 3).
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of three experiments performed in triplicate. * Significantly different (p < 0.05) with respect to
oxLDL-stimulated macrophages.
3.3. Phenolic Compounds and Carotenoids of Sofrito Did Not Affect the Binding and Uptake of oxLDL
by Macrophages
We also examined the effects of these compounds found in sofrito on the binding and uptake of
oxLDL using Dil-labelled oxLDL. As shown in Table 3, incubation of macrophages with Dil-labelled
oxLDL (50µg protein/mL) resulted in a marked increase in fluorescence intensity, while autofluorescence
of the sample prepared from cells stimulated with unlabelled oxLDL, was less than 10 units, findings
that demonstrated an oxLDL uptake by macrophages. Under these conditions, naringenin (10 µM),
hydroxytyrosol (10 µM), lycopene (50 µM), or β-carotene (50 µM) did not modify fluorescence intensity
induced by Dil-labelled oxLDL, whereas fucoidan (10 µg/mL), a polyanionic polysaccharide, effective
competitor for oxLDL in studies of receptor binding [28], prevented the increase in fluorescence
intensity. Thus, the above effects induced by oxLDL on oxidative stress and eicosanoid production
were not consequence of any disturbance of oxLDL binding to macrophages.
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Table 3. Effect of sofrito compounds on binding and/or uptake of Dil-labelled oxLDL. Macrophages
were incubated with the compounds for 1 h, and then incubated with Dil-oxLDL (50 µg protein/mL)
for 3 h. Then, the cells were washed and lysated and the fluorescence intensity in the lysates were
measured. Data are the means ± SEM of three experiments performed in duplicate. * Significant
different from non-treated cells incubated with Dil-oxLDL.
Fluorescence Intensity (Arbitrary Units)
oxLDL 21.2 ± 1.5
Dil-oxLDL 532.2 ± 21.3
Dil-oxLDL + Naringenin (10 µM) 476.7 ± 16.1
Dil-oxLDL + Hydroxytyrosol (10 µM) 453.4 ± 17.3
Dil-oxLDL + Lycopene (50 µM) 503.5 ± 13.8
Dil-oxLDL + β-Carotene (50 µM) 517.1 ± 12.8
Dil-oxLDL + Fucoidan (10 µg/mL) 102.6 ± 3.7 *
3.4. Naringenin 7-O-β-d-glucuronide Has Similar Activity on Oxidative Stress and Eicosanoid Biosynthesis
to Naringenin
Naringenin, once absorbed, is conjugated with sulphates and glucuronides by the enterocytes
and transported to the liver where it is also rapidly conjugated as other polyphenols [29]. Hence,
it is important to evaluate if naringenin’s antioxidant activity and other biological activities are
maintained after losing one or more hydroxyl groups of naringenin. Our results show that naringenin
7-O-β-d-glucuronide inhibits LDL oxidation induced by Cu2+ (Table 1) as well as oxidative stress and
eicosanoid synthesis induced by oxLDL in a similar extent to naringenin (Table 2).
4. Discussion
Atherosclerosis is thought to involve the uptake of oxLDL by macrophages and vascular wall
cells [30,31]. The generation of ROS and NO [32], as well as pro-inflammatory mediators such as
eicosanoids [33]. Characteristic bioactive compounds of sofrito such as hydroxytyrosol, naringenin,
lycopene, and β-carotene have been demonstrated to be effective as free radical scavengers [34–36].
Thus, the first question addressed by the present study was whether these bioactive compounds
present in sofrito were able to modulate LDL oxidation. Our findings demonstrated that both phenolic
compounds (hydroxytyrosol and naringenin) and both carotenoids (lycopene andβ-carotene) effectively
increased resistance to Cu2+-mediated LDL oxidation, being phenolic compounds more effective than
carotenoids. Interestingly, the simultaneous incubation of these compounds at concentrations that can
be reached in plasma after sofrito ingestion [37] induced a significant slow/inhibition of LDL oxidation.
These findings suggest an important additive and beneficial effect of bioactive sofrito compounds on
this event with a pivotal role in early steps of atherogenesis, as was previously reported using lycopene
in combination with other bioactive compounds [38].
The present work also shows that exposure to low, non-toxic levels of oxLDL, leads to the
production of ROS, NO, and eicosanoids by human macrophages obtained by differentiation of
THP-1 monocytes, in agreement with previous results obtained using murine macrophages RAW
264.7 [39]. Interestingly, these effects were observed when we examined an oxLDL concentration
capable of transforming macrophages into foam cells [40], a pivotal element in the development of
atheroma plaque.
Although several authors reported that olive oil or tomato phenolic compounds and carotenoids
modulate LDL oxidation or eicosanoid synthesis using different experimental models, the present
study is the first to quantitatively compare the effect of compounds found in sofrito on oxidative stress
and eicosanoid synthesis induced by oxLDL in macrophage cultures. The redox state of the cell may
act as a molecular switch regulating different genes and enzymes. Previously, we demonstrated that
changes of redox state of macrophages stimulated arachidonic acid cascade and consequently the
biosynthesis of eicosanoids [41–43]. In this way, Lupo et al. [44] demonstrated that oxLDL induced
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Ca2+-dependent as well as Ca2+-independent phospholipase A2, enzymes involved in arachidonic
acid release and consequently in eicosanoid synthesis. Furthermore, Muroya et al. [45] described that
oxLDL induced NFκB signalling, a redox-sensitive transcription factor involved in the regulation of
cyclooxygenase pathway in macrophages, a pivotal element in PGE2 synthesis. Considered all together,
we hypothesized that oxidative stress and eicosanoid synthesis induced by oxLDL can be modulated by
the sofrito compound tested. This hypothesis is supported by the fact that naringenin, hydroxytyrosol,
lycopene, andβ-carotene were able to inhibit O2−, NO2−, PGE2 and LTB4 production induced by oxLDL.
Obviously, sofrito is not a unique recipe throughout the Mediterranean countries and consequently
the bioactive compound profile can be more diverse. However, the above mentioned compounds
can be considered representative of this dish. The more interesting findings of the present study are
the additive effects observed when co-incubating macrophages with the phenols and carotenoids
tested on the modulation of oxidative stress and eicosanoid synthesis induced by oxLDL. Thus, the
simultaneous effects of sofrito bioactive compounds could result in an additional atheroprotective effect.
Sofrito preparation involves cooking often at a high temperature that can induce oxidation. However,
tomato cooking/processing maintains phenolic content and antioxidant activity [46]. Interestingly, such
effects take place at bioactive compound concentrations within the range expected from nutritional
intake of sofrito in the context of a Mediterranean type diet [37]. Furthermore, we must consider that
these bioactive compounds have been also described to modulate inflammatory elements involved
in atherogenesis such as cytokine release and adhesion molecules expression [47]. Other phenolic
compounds or carotenoids can also potentially contribute to the above beneficial effects of sofrito on
cardiovascular risk factors, especially when sofrito was cooked and enriched with olive oil [47]. Here,
our results suggest that the healthy effects of sofrito enriched with olive oil can be, at least in part, a
consequence of the presence of extra virgin olive oil rich phenolic compounds such as hydroxytyrosol.
Considering that oxLDL uptake and foam cell formation take place via scavenger receptors [48]
and that Miles et al. [49] described that olive oil, a component of sofrito, decreased macrophage uptake
of oxLDL though the down regulation of scavenger receptors, we attempted to explore whether sofrito
compounds influenced oxLDL interaction with macrophages in our experimental conditions. Our
findings demonstrated that the above effects of naringenin, hydroxytyrosol, lycopene, and β-carotene
were not due to interference with oxLDL binding to macrophage receptors. However, we can not
exclude that other bioactive compounds of sofrito could have this action. Thus, squalene present in
olive oil inhibits oxLDL uptake by macrophages, by reducing CD36 expression whereas tyrosol and
hydroxytyrosol did not have this effect [50], findings in agreement with our observations.
The maximum concentrations of naringenin and its metabolites generally appear in 30–60 min
after ingestion, and it found conjugated naringenin rather than its free form predominates in the
circulation [37]. Consequently, considerable controversy exists as to whether naringenin, or other
polyphenols, is an active molecule in vivo as its plasma concentration is in the nanomolar range
compared with the micromolar range of its metabolites. Previously, we demonstrated that resveratrol
metabolites are antioxidants and have similar biological effects to resveratrol [51]. Our findings
demonstrated that naringenin and naringenin 7-O-β-d-glucuronide, to a similar extent, reduce the
oxidative stress and eicosanoid synthesis induced by oxLDL and consequently both molecules may act
with additive effects on mechanisms with a central role in atherogenesis.
5. Conclusions
Recently, Tresserra-Rimbau and co-workers analysed the most relevant current knowledge of
bioactive polyphenols from culinary world to the clinical setting [52]. Here, our findings propose a
new molecular mechanism by which bioactive compounds of sofrito, a characteristic ingredient of the
Mediterranean diet, may prevent the biosynthesis of pro-inflammatory and pro-atherogenic mediators
by oxLDL-stimulated macrophages. Most relevantly, we demonstrated an important additive effect
of several sofrito compounds at physiological concentration, which can explain the beneficial effects
of cooked tomato sauce, as it was recently reported by Vilahur et al. [53] on coronary endothelial
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function of dyslipidemic animals. Finally, we also observed that naringenin metabolites, which reach
higher plasma concentrations than naringenin after oral ingestion, could be active to the same extent
as the parent compound. Obviously, additional experimental assays and clinical trials are necessary to
confirm the beneficial effects of sofrito inclusion in the diet.
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